Achieving Your Treatment Goals: Consider When a Treatment Switch in RA May Be the Right Transition For Your Patients
Exhibit Hall, Innovation Theater A
Developed and offered by AbbVie (Non-CME)
Loading view.
Patient Perspectives on Rheumatoid Arthritis Treatment Options
Exhibit Hall, Booth #3257
Developed and offered by SetPoint Medical (Non-CME)
A Dual Product Event: Ixekizumab and Tirzepatide
Exhibit Hall, Innovation Theater B
Developed and offered by Eli Lilly and Company (Non-CME)
Organ Damage in SLE: More Than Just the Kidneys
Exhibit Hall, Booth #3257
Developed and offered by GSK (Non-CME)
Early Initiation of Biologics and Organ Damage
Exhibit Hall, Booth #3257
Developed and offered by GSK (Non-CME)
The Clinical Relevance of Anti-DFS70 Autoantibodies
Exhibit Hall, Booth #3257
Developed and offered by Labcorp (Non-CME)
What You Need to Know about Sarcoidosis
Exhibit Hall, Booth #3257
Developed and offered by the Foundation for Sarcoidosis Research (Non-CME)
A Call for Early SLE Intervention in Minoritizied Patients
Exhibit Hall, Booth #3257
Developed and offered by GSK (Non-CME)
Q&A/Continue the Conversation
Exhibit Hall, Booth #3257
(Non-CME)
Collaborative Frameworks in CAR T-Cell Therapy for Autoimmune Diseases
Exhibit Hall, Innovation Theater A
Developed and offered by Bristol Myers Squibb (Non-CME)
Real-World Solutions: The Role of Novel Biomarkers in Diagnosing SLE and RA
Exhibit Hall, Innovation Theater B
Developed and offered by Exagen (Non-CME)
Changing the Treatment Paradigm in Recurrent Pericarditis (RP): Moving Beyond an Episodic Approach
Exhibit Hall, Innovation Theater A
Developed and offered by Kiniksa Pharmaceuticals (Non-CME)
Expert Perspectives on Dual Inhibition of IL-17A + IL-17F: A Different Mechanism of Action
Exhibit Hall, Innovation Theater B
Developed and offered by UCB (Non-CME)
What We Know About This Oral Medication in Moderate-to-Severe Plaque Psoriasis and Its 4-Year Data
Marriott Marquis, Room Capitol/Congress
Developed and offered by Bristol Myers Squibb (Non-CME)
Does Control of Inflammation Matter? Striving for Better Patient Outcomes in PsA and axSpA
Marriott Marquis, Room Liberty I/J/K/L
Developed and offered by UCB (Non-CME)
Advances in Systemic Lupus Erythematosus (SLE) Management: An Expert Discussion on Treat-to-Target Approaches and a Clinical Data Review of a Novel Treatment Option
Marriott Marquis, Room Independence E/F/G/H
Developed and offered by AstraZeneca (Non-CME)
Unraveling IL-23, the Common Thread Across Psoriasis, Psoriatic Arthritis, and Ulcerative Colitis
Marriott Marquis, Room Catholic University/University of DC
Developed and offered by Johnson & Johnson (Non-CME)
Upcoming Featured Industry Events
Popular Articles
-
Daltroy Lecture Examines the Psychological Impacts of Living with Rheumatic Disease
-
ARP Distinguished Lecture: Better Understanding of AI Will Enhance Its Utility for Rheumatologists
-
FDA Gives Updates on Newly Approved Agents for Rheumatic Diseases
-
Clinicians Discuss Experience Using Ambient Listening Technology in Clinical Practice
-
Opening Session Keynote Spotlights the Crucial Role of Allyship in Rheumatology